ArrowMark Colorado Holdings’s Relay Therapeutics RLAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.87M | Hold |
541,124
| – | – | 0.03% | 232 |
|
|
2025
Q1 | $1.42M | Hold |
541,124
| – | – | 0.02% | 239 |
|
|
2024
Q4 | $2.23M | Hold |
541,124
| – | – | 0.03% | 227 |
|
|
2024
Q3 | $3.83M | Hold |
541,124
| – | – | 0.05% | 205 |
|
|
2024
Q2 | $3.53M | Sell |
541,124
-3,464,046
| -86% | -$22.6M | 0.04% | 225 |
|
|
2024
Q1 | $33.2M | Buy |
4,005,170
+90,924
| +2% | +$755K | 0.37% | 72 |
|
|
2023
Q4 | $43.1M | Buy |
3,914,246
+103,667
| +3% | +$1.14M | 0.48% | 63 |
|
|
2023
Q3 | $32M | Buy |
3,810,579
+391,910
| +11% | +$3.3M | 0.39% | 75 |
|
|
2023
Q2 | $42.9M | Buy |
3,418,669
+748,472
| +28% | +$9.4M | 0.47% | 69 |
|
|
2023
Q1 | $44M | Sell |
2,670,197
-16,514
| -0.6% | -$272K | 0.5% | 60 |
|
|
2022
Q4 | $40.1M | Buy |
2,686,711
+174,243
| +7% | +$2.6M | 0.48% | 66 |
|
|
2022
Q3 | $56.2M | Sell |
2,512,468
-328,205
| -12% | -$7.34M | 0.69% | 48 |
|
|
2022
Q2 | $47.6M | Buy |
2,840,673
+815,559
| +40% | +$13.7M | 0.54% | 61 |
|
|
2022
Q1 | $60.6M | Sell |
2,025,114
-8,210
| -0.4% | -$246K | 0.53% | 58 |
|
|
2021
Q4 | $62.4M | Buy |
2,033,324
+1,590,591
| +359% | +$48.8M | 0.5% | 61 |
|
|
2021
Q3 | $14M | Buy |
442,733
+70,538
| +19% | +$2.22M | 0.11% | 155 |
|
|
2021
Q2 | $13.6M | Buy |
372,195
+32,759
| +10% | +$1.2M | 0.1% | 164 |
|
|
2021
Q1 | $11.7M | Sell |
339,436
-841
| -0.2% | -$29.1K | 0.09% | 181 |
|
|
2020
Q4 | $14.1M | Sell |
340,277
-4,677
| -1% | -$194K | 0.11% | 144 |
|
|
2020
Q3 | $14.7M | Buy |
+344,954
| New | +$14.7M | 0.14% | 120 |
|